Sally Curley

Sally is Founder and CEO of Curley Global IR, LLC, an Investor Relations, Environmental-Social-Governance Survey and Corporate Governance strategic advisory firm. With more than 30 years of business experience, Sally has worked for and represented companies in the healthcare, high tech, software and retail industries. For nearly a decade, Sally served as Senior Vice President, Investor Relations for Cardinal Health, a Fortune 50 global healthcare services company, where she was a member of the Global Leadership Team and oversaw the company’s worldwide IR efforts. Prior to Cardinal Health, Sally was Vice President, Investor Relations for Genzyme Corporation (now Sanofi), where for nine years she led global IR and helped to advise its Board’s Nominating and Governance Committee on corporate governance issues. In both organizations, she grew the domestic and international shareholder base substantially. She currently is Adjunct Faculty at Georgetown University. She holds a B.A. from Colby College, an M.B.A. from Northeastern University, and a Certificate of Biotechnical Education from Boston University Medical School.